Takeda to target 4,500 jobs as incoming CEO continues restructuringnews2026-05-13T18:36:06+00:00May 13th, 2026|Endpoints News|
Valneva to cut up to 15% of jobs as reduced travel hits vaccine demandnews2026-05-13T17:46:51+00:00May 13th, 2026|Endpoints News|
Behind Galapagos’ transformation into Lakefront Biotherapeuticsnews2026-05-13T13:30:48+00:00May 13th, 2026|Endpoints News|
Merck KGaA’s clients are stockpiling due to Iran war, supporting guidance boostnews2026-05-13T11:01:36+00:00May 13th, 2026|Endpoints News|
Lilly points to low-dose Zepbound and Foundayo as weight loss maintenance optionsnews2026-05-12T22:01:09+00:00May 12th, 2026|Endpoints News|
EU reaches provisional deal on Critical Medicines Actnews2026-05-12T17:47:10+00:00May 12th, 2026|Endpoints News|
Iran war disruptions begin to emerge upstream of the pharma supply chainnews2026-05-12T17:04:25+00:00May 12th, 2026|Endpoints News|
Bayer to make ‘careful but aggressive’ return to pharma M&A, CEO saysnews2026-05-12T14:06:30+00:00May 12th, 2026|Endpoints News|
Bristol Myers joins Hengrui party in 13-asset deal worth up to $15.2Bnews2026-05-12T09:06:30+00:00May 12th, 2026|Endpoints News|
Optum Rx unveils pharmacy model with clear fees, building on transparency pushnews2026-05-11T20:05:00+00:00May 11th, 2026|Endpoints News|
